Use LEFT and RIGHT arrow keys to navigate between flashcards;
Use UP and DOWN arrow keys to flip the card;
H to show hint;
A reads text to speech;
103 Cards in this Set
- Front
- Back
What types of anticoagulant drugs do we know?
|
direct and indirect thrombin inhibitors, vitamin K antagonist
|
|
Direct thrombin inhibitors?
|
argatroban, dabigatran
Bivalent: Bivalrudin, leprudin, Hirudin, |
|
Indirect thrombin inhibitors?
|
Heparin (UFH,LMWH), Fondaparinux
|
|
Vitamin K antagonists?
|
Warfarin
|
|
UFH's MOA?
|
interacts w/ AT to inactivate thrombin (IIa), IXa (plasma thromboplastin component/christmas factor), Xa (stuart prower), XIa (plasma thromboplastin antecedent), XIIa (hageman)
|
|
LMWH's MOA? Administration?
|
Inhibits Xa>thrombin; Weight based
|
|
What are the LMWH? How dosed?
|
enoxaprin(mg); dalteparin & tinzaparin: (anti factor Xa units)
|
|
UFH vs LMWH
|
LMWH less tox and dose frequency, only monitored in special populations
|
|
How is UFH administerd? what route should be avoided?
|
given IV,SC; avoid IM: risk of hematoma
short t1/2 (1hr) |
|
Which heparin needs close monitoring? How?
|
UFH, aPTT(intrinsic) or protamin titration or anti-Xa units
|
|
What drug should be used if HIT occurs? Which heparin is HIT most commonly associated?
|
Discontinue heparin and use DTI or fondaparainux; UFH
|
|
Symptoms of HIT? Cause?
|
decrease platelet count, new thrombus, thrombocytopenia, bleeding;
Antibodies against heparin/platelet factor 4cplx |
|
What is heparin? Where does it come from?
|
Mixture of sulfated mucopolysaccharides extracted from porcine gut or bovine lung
|
|
How do Indirect thrombin inhibitors work?
|
Use AT to Inactivate(2,9,10,11,12) thrombin IIa, plasma thromboplastin components/ chritmas factor IXa, stuart prowerXa, plasma thromboplastin antecedent XIa, hageman XIIa
Also, Heparin increases lipoprotein lipase(clear lipemia) |
|
How to reverse UFH?
|
Protamine sulfate
|
|
Can protamin sulfate reverse fondaparinux?
|
No Ineffective reversal for fondaparinux
|
|
Can protamin sulfate reverse LMWH?
|
Yes, but incompletlly for LMWH
|
|
fondaparinux MOA?
|
identical to UFH, inactivates IIa, IXa, Xa, XIa, XIIa through interactions w/ AT
|
|
Fondaparinux Adminstration?
|
once daily SC long t1/2;
|
|
Fondaparinux indications?
|
the synthetic pentasaccharide is a prophylaxis/treatment of venous thromboemobolism, alternate for HIT
|
|
What are the Univalent DTI's?
|
argatroban, dabigatran
|
|
What is argatroban and dabigatran MOA?
|
Bind to the active site of the thrombin enzyme
|
|
Which DTIs are bivalent and what is there MOA?
|
Hirudin, lepirudin, bivalirudin; bind to thrombin and the substrate site (site which molecules that interact w/ thrombin use to bind)
|
|
Which Bivalent DTI is irreversible?
|
Hirudin
|
|
Which bivalent DTI inhibits platelet activation?
|
Bivalirudin
|
|
Which bivalent DTI prefered for HIT?
|
Lepirudin
|
|
Which bivalent DTI has rapid on/off action and is given IV?
|
Bivalirudin
|
|
What is the oral prodrug to argatroban?
|
dabigatran
|
|
Univalent used for HIT?
|
argatroban
|
|
argatroban administration?
|
IV
|
|
What should be monitored w/ agatroban?
|
aPTT
|
|
What is dabigatran the oral prodrug for?
|
argatroban
|
|
What is the oral prodrug to argatroban?
|
dabigatran?
|
|
Argatroban increases ___ and has inhibitory effects on____?
|
Increases INR and inhibits Protein C and platelet aggregation through thrombin
|
|
what enzyme does warfarin inhibit?
|
Vitamin K epoxide reductase. so there is no vit k reduced for gamma glutamyl carboxylase to act on
|
|
Warfarin MOA?
|
Block gamma carboxylation of glutamate residue in prothrombin, VII, IX, X protein C & S
|
|
What is the delay before warfarin acts
|
8-12 hour delay
|
|
What does vitamin K do?
|
carboxylate glutamic acid
|
|
What are the substrates for Vit K glutamic acid carboxylation?
|
vit k carboxylated glutamic acid on II,VII,IX,X
|
|
Which warfarin enantomer is more potent
|
S
|
|
does warfarin have a long half life?
|
yes 36hr
|
|
What is the largest loading does that can facilitate onset of warfarin?
|
.75mg/kg
|
|
Above .75mg/kg loading dose what is the effect?
|
NO increase in onset, only prolonged action
|
|
should warfarin be used for pregnant women?
|
No crosses placenta, fetal hemorrhage, birth defects (blood bone proteins)
|
|
Anticoagulant used in pregnant?
|
Heparin, dose not cross placenta
|
|
Warfarin adverse reactions?
|
Skin necrosis aka WISN, venous thrmonisis (decrease protein C) worse w/ large loading dose
|
|
warfarin adminstration?
|
oral typically std dose 5-10mg then increased acording to PT to maintain 25% normal or 2-3 INR. Avoid going below 20%
INR= p’t PT/mean of normal PT for lab |
|
Reduces warfarin effect?
|
Inducers of P450
barbiturates, cholestyramine, rifampin, diuretics, vit K |
|
Reverse warfarin?
|
Vit k1(phytonadione, fresh frozen plasma, prothrombin cplx concentrates, rFVIIa
|
|
Stop warfarin
|
excessive anticoaglulant w/ or w/o bleeding
|
|
Streptokinase MOA
|
catalyst: plasminogen to plasmin via cplx w/ proactivator plasminogen
|
|
Urokinase MOA
|
Converts plasminogen to plasmin
|
|
Thrombolytic drug categories?
|
Plasminogen activators,
Recombinant tPA |
|
Streptokinase origin
|
bacterial protein streptococci
|
|
Urokinase Origin
|
synthesized in human kidney
|
|
Recombinant tissue plasminogen activators (t-PAs)
|
Alteplase & reteplase
|
|
Mutant recombinant t-PA
|
Tenecteplase
|
|
Preferentially activate fibrin bound plasminogen
|
alteplase and reteplase
|
|
Thrombolytic drugs clinical uses?
|
IV, pulmonary embolism w/ hemodynamic instability, deep venous thrombosis, & ascending thrombophlebitis w severe lower extremity edema;
acute MI |
|
r t-PA unique use?
|
acute ischemic stroke
|
|
______ by ADP (blocked by clopidogrel) leads to a conformational change in platelet gpIIb/IIIa receptors that induces binding to fibrinogen
|
Platelet activation
|
|
r t-PA MOA
|
activates plasminogen to release enzyme plasmin
|
|
ADP R antagonist?
|
clopidrogel, ticlopidine
|
|
Thromboxane inhibitor?
|
Asprin
|
|
GPIIIa/IIb R antagonist
|
abciximab, eptifibatide, tirofiban
|
|
Antiplatelet categories?
|
ADP R antagonist, Thromboxane inhibitor, GPIIIa/IIb R antagonist
|
|
Asprin antiplatelet MOA
|
irreversibly inhibits TXA2 synthesis via acetylation of COX enzyme
|
|
Primary prophylazis of MI
|
325 mg/dl asprin
|
|
PAR1
|
thrombin receptor protease activated
|
|
P2Y12 & 1
|
ADP receptor: g protein bound
|
|
Clopidrogel, ticlopidine MOA
|
Inhibitt P2Y12 on platelet
|
|
Prodrug useful for patients who cant tolerate asprin
|
Clopidrogel
|
|
Clopidrogel, ticlopidine Uses?
|
prevent thrombosis
|
|
Ticlopidine> clopidrogel toxicity?
|
Gi tox, hemorrahge, thrombotic thrombocytopenic purpura TTP, neutropenia
|
|
Proton pump inhibitors (omeprazole)
|
should be avoided w/ clopidrogel, reduces antiplatelet activty
|
|
activators of GPIIb/IIIa that aid activation of platelet aggregation
|
ADP, serotonin, shear forces, epinepherin, plasmin, thrombin, collagen, PAF, TXA2
|
|
Abciximab MOA?
|
Chimeric mAB that blocks gpIIb/IIIa & vibronectin
|
|
Eptifibatide MOA?
|
fibrinogen delta chain analog block binding of fibrinogen to IIb/IIIa
|
|
Tirofiban MOA?
|
similar to eptifabitide
|
|
vibronectin
|
extracellular matrix protein on endothelial and platelets.
adhesion molecule in the integrin family. |
|
Types of drugs that facilitate clotting?
|
Vit K, clotting factors, fibrinolytic inhibitors, serine protease inhibitors
|
|
Factor VIII deficiency
|
Hemophilia A
|
|
Factor VIII
|
antihemophilic factor
|
|
Christmas disease
|
Hemophilia B
|
|
Factor Ix deficiency
|
Hemophilia B
|
|
comsumption coagulopathy
|
DIC (disseminated intravascular coagulation disorder)
|
|
Lab findings to diagnose DIC
|
Fibrin degredation products
|
|
DIC natural course
|
hypercoagulability succeeded by deficiency in clotting factors w/ hypocoagulability and hemorrhaging
|
|
Factor XI deficiency
|
hemophilia C
|
|
Factor VII deficiency
|
aka serum prothrombin conversion accelerator (SPCA) deficiency
|
|
Types used to facilitate clotting
|
Vit K, antiplasmin, clotting factors
|
|
Antiplasmin drugs
|
aminocaproic acid, aprotinin
|
|
Clotting factors used to facilitate clotting clinically
|
VII, VIII, IX,X, fresh frozen plasma (FFP) cryoprecipitate
|
|
antiplasmin drugs are?
|
fibrinolytic inhibitors
|
|
Vit K is?
|
fat soluble, K1 (phytonadione):leafy green veggies, K2(menaquinone): human intestinal bacteria
K3:menadione not for therapeutic use (water soluble) |
|
What to avoid w/ vitamin K?
|
rapid infusion ( dyspnea, chest/back pain, SC-erratic bioavailability
|
|
Vit K clinical use?
|
depression of prothrombin by warfarin, vit K deficiency; Given to all newborns as prophylaxis
|
|
protein C is a?
|
Vit K dependent serine protease.
|
|
Protein C is activated by?
|
Activated by thrombin to APC.
|
|
Protein C degrades?
|
Degrades cofactor Va & VIIIa
|
|
Protein C deficiency can lead to?
|
Increased thrombis
|
|
Protein S is a?
|
Vit K dependent glycoprotein
|
|
The two forms of protein S?
|
Free and C4b bound
|